HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Hillhouse Capital Related

469.111

-4.840-1.02%

Number of Gainers:18

Number of Losers:29

Number of Flat:4

PE:- -

High:475.542

Open:474.006

Low:466.941

Close:473.951

Volume:397.13M

Turnover:11.96B

Market Cap:2.95T

Float Cap:2.06T

Loading ...

Innovent Biologics' Outlicensing Drug Deals Could Remain Key Share-Price Driver

Belgium's Materialise NV Q2 Revenue Rises 8% on Medical Segment Strength

China's Drug Regulator Accepts Novo Nordisk's Application for Oral Wegovy

Press Release: Junshi Biosciences Announces 2026 Interim Financial Results and Provides Corporate Updates

Junshi Biosciences Reports First-Half Net Profit of RMB21.66 Million, Reversing Year-Earlier Loss

Boston Scientific Hit by Cyberattack, Shares Slide on Delivery Disruption

Microport Cardioflow Medtech Says Zhang Ruinian Has Resigned as CEO

MP CARDIOFLOW-B Announces New Leadership Appointments

MicroPort CardioFlow Delays Board Meeting on Interim Results Release

MicroPort CardioFlow Files Board and Committee Member List with Disclosure Roles

Microport Cardioflow Medtech - Zhang Ruinian Has Resigned as Chief Executive Officer, Appointed as President

THOMSON REUTERS

Microport Cardioflow Medtech - Brian Chang Has Been Appointed as Chairman

THOMSON REUTERS

MicroPort CardioFlow Names Chen Guoming CEO, Replacing Zhang Ruinian

Stronger Half Year Earnings And Profitability Could Be A Game Changer For Hansoh (SEHK:3692)

Simply Wall St.

Grand Pharmaceutical H1 Revenue Rises on Nuclear Medicine Demand

Microport Scientific - Shanghai Microport Endovascular Medtech Hy Revenue of Rmb793.95 Mln

THOMSON REUTERS

Conch Cement Reports Interim Results with 41.85% Decline in Shareholder Profit

Lee's Pharmaceutical Flags Higher Interim Profit as Revenue and Margins Improve

Hansoh Pharmaceutical Cuts Convertible Bond Conversion Price to Hk$56.54 Per Share

AK MEDICAL Reports 22.5% Profit Surge in Interim Results

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/BK1583/news?page=12"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1583","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","market":"HK","secType":"PLATE","nameCN":"Hillhouse Capital Related","latestPrice":469.11102,"timestamp":1788250091886,"preClose":473.95062,"halted":0,"volume":397125506,"delay":0,"changeRate":-0.010211,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-4.8396,"latestTime":"09-01 16:00:00","open":474.00632,"high":475.5418,"low":466.94058,"amount":11957903003,"amplitude":0.018148,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788312600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1788226200000,1788235200000],[1788238800000,1788249600000]],"pbRate":2.140289,"peRate":44.408694,"turnoverRate":0.003652,"increases":16,"decrements":29,"flats":4,"marketCap":2949796327648,"floatMarketCap":2064055102368},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","high":475.5418,"amplitude":0.018148,"preClose":473.95062,"low":466.94058,"pbRate":"2.140289","latestPrice":469.11102,"volume":397125506,"delay":0,"open":474.00632,"prevYearClose":503.90085,"prevWeekClose":483.681,"prevMonthClose":473.951,"prevQuarterClose":402.118,"fiveDayClose":475.733,"twentyDayClose":471.019,"sixtyDayClose":425.31,"secType":"PLATE","market":"HK","turnoverRate":0.003652,"peRate":44.408694,"marketCap":2949796327648,"floatMarketCap":2064055102368,"timestamp":1788250091886,"nameCN":"Hillhouse Capital Related"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1583\",,,,undefined,":{"bkCode":"BK1583","up":18,"down":29,"flat":4},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1583\",pageSize:20,pageCount:12,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662773368","title":"Innovent Biologics' Outlicensing Drug Deals Could Remain Key Share-Price Driver","url":"https://stock-news.laohu8.com/highlight/detail?id=2662773368","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662773368?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:01","pubTimestamp":1787810460,"startTime":"0","endTime":"0","summary":"0601 GMT - Innovent Biologics' outlicensing drug deals with multinational corporations could remain a key share-price driver, say DBS Group Research analysts in commentary. The Chinese biopharmaceutical company's previous deal with Pfizer in May boosted its stock by around 33% over two months. Innovent likely has around three early stage treatment products that could yield around $955 million in upfront payments, the analysts estimate. The company's balance sheet also remains strong, with net cash of around 16.2 billion yuan as of June, they add. DBS Group Research maintains its buy rating and 144.00 Hong Kong dollar target price. Shares drop 2.55% to HK$107.00.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242644610.SGD","BK1589","KURE","LU2097828714.EUR","01801","LU0463099449.HKD","LU2097828805.USD","LU0502904849.HKD","LU2328871848.SGD","LU0455707207.USD","HK0000165453.HKD","LU0244354667.USD","LU1969619763.USD","LU2097828474.EUR","BK1583","BK1161","LU2097828631.EUR","LU1188198961.HKD","LU2097828557.USD","LU2488822045.USD","LU0326950275.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662572044","title":"Belgium's Materialise NV Q2 Revenue Rises 8% on Medical Segment Strength","url":"https://stock-news.laohu8.com/highlight/detail?id=2662572044","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662572044?lang=en_us&edition=fundamental","pubTime":"2026-08-27 13:11","pubTimestamp":1787807477,"startTime":"0","endTime":"0","summary":"Belgium's Materialise NV Q2 revenue rises 8% on medical segment strengthOverviewBelgium 3D-printed medical device firm's Q2 revenue rose 8% yr/yr to 70 mln EURQ2 net profit climbed to 3.3 mln EUR from","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL1N44O051:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ROKT","BK1583","IE00BD6J9T35.USD","BK4559","BK1617","01789","BK1100","BK1585","BK4187","HEI","MISL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662727075","title":"China's Drug Regulator Accepts Novo Nordisk's Application for Oral Wegovy","url":"https://stock-news.laohu8.com/highlight/detail?id=2662727075","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662727075?lang=en_us&edition=fundamental","pubTime":"2026-08-27 12:42","pubTimestamp":1787805765,"startTime":"0","endTime":"0","summary":"UPDATE 2-China's drug regulator accepts Novo Nordisk's application for oral WegovySHANGHAI, Aug 27 (Reuters)-Novo NordiskNOVOb.COsaid on Thursday that China's drug regulator had accepted its applicati","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL6N44O09E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242644610.SGD","BK1589","KURE","IE000M9KFDE8.USD","LU0321505868.SGD","01801","IE00BLSP4239.USD","LU0463099449.HKD","IE00BBT3K403.USD","SG9999001176.USD","LU0502904849.HKD","LU2596442595.SGD","LU0225771236.USD","LU2328871848.SGD","BK4588","IE00B19Z3B42.SGD","LU0455707207.USD","SG9999002224.SGD","HK0000165453.HKD","LU0058720904.USD","LU0321505439.SGD","PFE","LU0122379950.USD","BK4568","LU2097828474.EUR","LU1894683264.USD","IE0002270589.USD","BK1583","BK1161","BK4599","SGXZ57979304.SGD","LU2097828631.EUR","BK4007","SG9999002232.USD","LU1057294990.SGD","LU0170899867.USD","SG9999011175.SGD","OZEM","LU0868494617.USD","IE00BLSP4452.SGD","LU1894683348.USD","BK4533","LU2097828557.USD","SG9999001176.SGD","00673","LU0456855351.SGD","BK4581","LU0985481810.HKD","IE00B19Z3581.USD","BK1197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662727363","title":"Press Release: Junshi Biosciences Announces 2026 Interim Financial Results and Provides Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2662727363","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662727363?lang=en_us&edition=fundamental","pubTime":"2026-08-27 11:58","pubTimestamp":1787803080,"startTime":"0","endTime":"0","summary":"SHANGHAI, Aug. 26, 2026  -- Shanghai Junshi Biosciences Co., Ltd , a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its 2026 interim financial results and provided corporate updates.FINANCIAL HIGHLIGHTS-- As of June 30, 2026, the company's total revenue was approximately. RMB1,696 million for the first half of 2026 , a 45% increase. compared to 2025, which was made possible by the rise in sales revenue of. pharmaceutical products. In particular, the domestic sales revenue of our. core product, toripalimab, reached approximately RMB1,299 million, around. 36% more than in 2025. In addition, out-licensing revenue also increased. by approximately RMB152 million, an approximately 149% improvement from. -- Total research and development  expenses of the company were. approximately RMB644 million for 2026H1, which was primarily used to. advance the construction of our R&D technology platforms, ex","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01877","BK4022","BK1515","BK4232","BK1583","R","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178598132","title":"Junshi Biosciences Reports First-Half Net Profit of RMB21.66 Million, Reversing Year-Earlier Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=1178598132","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178598132?lang=en_us&edition=fundamental","pubTime":"2026-08-27 00:20","pubTimestamp":1787761218,"startTime":"0","endTime":"0","summary":"Shanghai Junshi Biosciences Co., Ltd. has announced its financial results for the first half of 2026, revealing a notable turnaround in profitability.During the reporting period, the company...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","01877","BK1161","688180","BK0239","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163553180","title":"Boston Scientific Hit by Cyberattack, Shares Slide on Delivery Disruption","url":"https://stock-news.laohu8.com/highlight/detail?id=1163553180","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163553180?lang=en_us&edition=fundamental","pubTime":"2026-08-26 23:30","pubTimestamp":1787758250,"startTime":"0","endTime":"0","summary":"Boston Scientific disclosed in a Wednesday filing with the U.S. Securities and Exchange Commission (SEC) that it has been struck by a cyberattack, impacting its business operations. The incident is...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4504","LU2491050071.SGD","LU0011850046.USD","LU2506951958.HKD","LU2491050154.USD","SPAM","LU1989772923.USD","SG9999001176.SGD","IE0002141913.USD","IE00BJT1NW94.SGD","LU0187121727.USD","LU1718418525.SGD","SGXZ57979304.SGD","UCYB","BK4585","HAKY","LU0138981039.USD","LU1989764664.SGD","MDEV","LGHT","BK1574","LU1057294990.SGD","LU0528227936.USD","LU0882574055.USD","IE0009355771.USD","LU2357305700.SGD","LU0823417737.USD","LU0823417653.USD","LU1548497426.USD","LU1720051017.SGD","HART","SG9999001176.USD","IE00B4R5TH58.HKD","LU0077335932.USD","LU0345769128.USD","LNGR","LU1804176565.USD","BK4581","RSPH","BK1583","WCBR","LU2244417387.USD","LU2506952097.USD","LU0266013472.USD","LU2242649171.HKD","IE00B2B36J28.USD","LU1791710400.SGD","LU1061106388.HKD","LU2491049909.HKD","PTH","LU0238689110.USD","BK4588","LU2506951875.HKD","LU1989764748.USD","LU0122379950.USD","LU2506952170.USD","LU1720051108.HKD","LU1791710582.SGD","LU0353189680.USD","09996","IE00BFTCPJ56.SGD","LU1023059063.AUD","LU0267386448.USD","LU2265009873.SGD","LU2362540622.SGD","LU0225283273.USD","LU2324357040.USD","BSX","SG9999013999.USD","LU1989771016.USD","LU0048584097.USD","BK1100","IEIH","BK4082","LU2362541273.HKD","LU0950375773.USD","LU0114720955.EUR","LU1153585028.USD","AGNG","LU0353189763.USD","IE00BJJMRZ35.SGD","LU2087625088.SGD","GDOC","LU0823416689.USD","LU1983299246.USD","LU0432979614.USD","MEDX","LU0345769631.USD","LU1291159041.SGD","LU1366192091.USD","LU2112291526.USD","159883","LU0251132253.USD","LU1989772840.SGD","LU2362541513.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662106748","title":"Microport Cardioflow Medtech Says Zhang Ruinian Has Resigned as CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2662106748","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662106748?lang=en_us&edition=fundamental","pubTime":"2026-08-26 23:08","pubTimestamp":1787756895,"startTime":"0","endTime":"0","summary":"BRIEF-Microport Cardioflow Medtech Says Zhang Ruinian Has Resigned As CEOAug 26 -Microport Cardioflow Medtech Corp2160.HK:ZHANG RUINIAN HAS RESIGNED AS CHIEF EXECUTIVE OFFICER, APPOINTED AS PRESIDENTCHEN GUOMING RESIGNED AS CHAIRMAN, RE-DESIGNATED TO EXECUTIVE DIRECTOR, APPOINTED AS CEOBRIAN CHANG HAS BEEN APPOINTED AS CHAIRMANFurther company coverage:2160.HK","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N169:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02160","BK1100","BK1583","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128341122","title":"MP CARDIOFLOW-B Announces New Leadership Appointments","url":"https://stock-news.laohu8.com/highlight/detail?id=1128341122","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128341122?lang=en_us&edition=fundamental","pubTime":"2026-08-26 23:02","pubTimestamp":1787756533,"startTime":"0","endTime":"0","summary":"MP CARDIOFLOW-B (02160) has announced a series of executive changes effective August 26, 2026. Mr. Zhang Ruinian has stepped down from his role as Chief Executive Officer and has been appointed as...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02160","BK1100","BK1583","BK1225","BK1574","02918","BK1239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662573748","title":"MicroPort CardioFlow Delays Board Meeting on Interim Results Release","url":"https://stock-news.laohu8.com/highlight/detail?id=2662573748","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662573748?lang=en_us&edition=fundamental","pubTime":"2026-08-26 22:58","pubTimestamp":1787756331,"startTime":"0","endTime":"0","summary":"MicroPort CardioFlow delays board meeting on interim results releaseMicroPort CardioFlow Medtech rescheduled its board meeting to Aug. 31, 2026, from Aug. 26, 2026.Session will review interim results ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL6mSG1y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","BK1574","BK1100","02160","BK1585","00853","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662574857","title":"MicroPort CardioFlow Files Board and Committee Member List with Disclosure Roles","url":"https://stock-news.laohu8.com/highlight/detail?id=2662574857","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662574857?lang=en_us&edition=fundamental","pubTime":"2026-08-26 22:58","pubTimestamp":1787756324,"startTime":"0","endTime":"0","summary":"MicroPort CardioFlow files board and committee member list with disclosure rolesMicroPort CardioFlow Medtech (2160) updated its board and committee lineup in a filing dated Aug. 26, 2026.Brian Chang l","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL7XTd8n:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1585","BK1583","BK1589","02160","00853","BK1100","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662748578","title":"Microport Cardioflow Medtech - Zhang Ruinian Has Resigned as Chief Executive Officer, Appointed as President","url":"https://stock-news.laohu8.com/highlight/detail?id=2662748578","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662748578?lang=en_us&edition=fundamental","pubTime":"2026-08-26 22:58","pubTimestamp":1787756316,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N169:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1583","BK1574","BK1100","02160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662485717","title":"Microport Cardioflow Medtech - Brian Chang Has Been Appointed as Chairman","url":"https://stock-news.laohu8.com/highlight/detail?id=2662485717","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662485717?lang=en_us&edition=fundamental","pubTime":"2026-08-26 22:58","pubTimestamp":1787756316,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N169:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1100","BK1574","BK1583","02160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662748576","title":"MicroPort CardioFlow Names Chen Guoming CEO, Replacing Zhang Ruinian","url":"https://stock-news.laohu8.com/highlight/detail?id=2662748576","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662748576?lang=en_us&edition=fundamental","pubTime":"2026-08-26 22:58","pubTimestamp":1787756289,"startTime":"0","endTime":"0","summary":"MicroPort CardioFlow names Chen Guoming CEO, replacing Zhang RuinianMicroPort CardioFlow Medtech named Guoming Chen chief executive, replacing Ruinian Zhang, effective Aug. 26, 2026.Chen stepped down ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDLb6bRcx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00853","02160","BK1589","BK1574","BK1583","BK1100","BK1585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662745499","title":"Stronger Half Year Earnings And Profitability Could Be A Game Changer For Hansoh (SEHK:3692)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662745499","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662745499?lang=en_us&edition=fundamental","pubTime":"2026-08-26 22:20","pubTimestamp":1787754056,"startTime":"0","endTime":"0","summary":"Hansoh Pharmaceutical Group Company Limited has reported past half-year results to June 30, 2026, with sales rising to CNY 8,304.01 million and net income increasing to CNY 4,257.94 million, lifting basic and diluted EPS from continuing operations to CNY 0.70.\nThe combination of higher revenue and a larger increase in net income suggests improved profitability and operating efficiency in Hansoh’s core business.\nWe will now explore how this improvement in earnings and profitability shapes...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3692/hansoh-pharmaceutical-group-shares/news/stronger-half-year-earnings-and-profitability-could-be-a-gam","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3692/hansoh-pharmaceutical-group-shares/news/stronger-half-year-earnings-and-profitability-could-be-a-gam","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1191","BK1589","BK1583","03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662717592","title":"Grand Pharmaceutical H1 Revenue Rises on Nuclear Medicine Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=2662717592","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662717592?lang=en_us&edition=fundamental","pubTime":"2026-08-26 21:54","pubTimestamp":1787752465,"startTime":"0","endTime":"0","summary":"Grand Pharmaceutical H1 revenue rises on nuclear medicine demandOverviewHong Kong-listed pharma group's H1 revenue rose 3.2% yr/yr to HK$6.39 blnNet income attributable to owners fell to HK$1.06 bln f","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL1N44N0MX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1600","BK1589","BK1515","00512","BK1191","00460","03692","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662173427","title":"Microport Scientific - Shanghai Microport Endovascular Medtech Hy Revenue of Rmb793.95 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2662173427","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662173427?lang=en_us&edition=fundamental","pubTime":"2026-08-26 21:50","pubTimestamp":1787752239,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N0NK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1583","00853","BK1100","BK1589","BK1585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116288019","title":"Conch Cement Reports Interim Results with 41.85% Decline in Shareholder Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=1116288019","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116288019?lang=en_us&edition=fundamental","pubTime":"2026-08-26 21:30","pubTimestamp":1787751055,"startTime":"0","endTime":"0","summary":"Conch Cement (00914) has released its interim results for the six-month period ended June 30, 2026. The group recorded operating revenue of RMB 36.927 billion, a year-on-year decrease of 10.88%....","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1594","00914","BK0044","BK0235","BK1563","BK0196","BK0015","BK0188","LU1328615791.USD","BK0183","600585","BK1583","BK0028","BK0187","BK1507","BK1505","BK1135","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184470015","title":"Lee's Pharmaceutical Flags Higher Interim Profit as Revenue and Margins Improve","url":"https://stock-news.laohu8.com/highlight/detail?id=1184470015","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184470015?lang=en_us&edition=fundamental","pubTime":"2026-08-26 21:28","pubTimestamp":1787750895,"startTime":"0","endTime":"0","summary":"Lee's Pharmaceutical Holdings Ltd (00950) has issued a positive profit alert, indicating that the group expects to report an audited net profit attributable to shareholders of between approximately...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","00950","06622","BK1583","BK1191","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662279711","title":"Hansoh Pharmaceutical Cuts Convertible Bond Conversion Price to Hk$56.54 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2662279711","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662279711?lang=en_us&edition=fundamental","pubTime":"2026-08-26 20:46","pubTimestamp":1787748384,"startTime":"0","endTime":"0","summary":"Hansoh Pharmaceutical cuts convertible bond conversion price to HK$56.54 per shareHansoh Pharmaceutical adjusted the conversion price on its HK$ 4.68 billion zero-coupon convertible bonds due 2033.Con","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDLc9h2j6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","03692","BK1583","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170704019","title":"AK MEDICAL Reports 22.5% Profit Surge in Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1170704019","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170704019?lang=en_us&edition=fundamental","pubTime":"2026-08-26 20:32","pubTimestamp":1787747544,"startTime":"0","endTime":"0","summary":"AK MEDICAL (01789) has released its interim results for the 2026 fiscal year, posting a revenue of approximately HK$765 million, reflecting a year-on-year increase of 10.2%.The company's profit...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01789","BK1583","BK1585","BK1100","BK1617"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":28,"pageCount":12,"totalSize":546,"code":"91000000","status":"200"}]}}